Skip to main content

Navigation group

Type at least 3 characters
809 articles

Articles

Original Research

Published on 29 Sep 2022

The efficacy and safety of conventional transcatheter arterial chemoembolization combined with PD-1 inhibitor and anti-angiogenesis tyrosine kinase inhibitor treatment for patients with unresectable hepatocellular carcinoma: a real-world comparative study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

  • Zheng Guo
  • Huabin Zhu
  • Xiufang Zhang
  • Li Huang
  • Xiangcai Wang
  • Huaqiu Shi
  • Li Yu
  • Yingwei Qiu
  • Fuping Tu
The efficacy and safety of conventional transcatheter arterial chemoembolization combined with PD-1 inhibitor and anti-angiogenesis tyrosine kinase inhibitor treatment for patients with unresectable hepatocellular carcinoma: a real-world comparative study
Frontiers in Oncology
doi 10.3389/fonc.2022.941068
  • 1,838 views
  • 4 citations